Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men – Data from the PROBASE Trial

European Urology · Published 2026-07-01 · DOI 10.1016/j.eururo.2026.06.016

Free full text

Authors (22)

Agne Krilaviciute, Nikolaus Becker, Sigrid V. Carlsson, Rudolf Kaaks, Petra Seibold, Jale Lakes, Rouvier Al-Monajjed, Markus Kuczyk, Nina N. Harke, Mohammed Rafea Kanaan, Jürgen Debus, Christoph A. Grott, Jakob Liermann, Jürgen E. Gschwend, Kathleen Herkommer, Victoria A. Göldner, Glen Kristiansen, Gerald Antoch, Lars Schimmöller, Christian Arsov, Boris Hadaschik, Peter Albers

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Krilaviciute, A., Becker, N., Carlsson, S., et al. (2026). Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men – Data from the PROBASE Trial. European Urology. https://doi.org/10.1016/j.eururo.2026.06.016

Related articles